Sangamo Therapeutics Inc (0R1D)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 0R1D market cap is 2.75B. The company's latest EPS is USD -1.4538 and P/E is -0.83.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 102.43M | 118.19M | 110.7M | 111.3M | 176.23M |
| Operating Income | -105.18M | -129.55M | -183.34M | -201.28M | -208.48M |
| Net Income | -95.19M | -121M | -178.29M | -192.28M | -257.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 637.52M | 938.55M | 721.92M | 562.51M | 165.32M |
| Total Liabilities | 204.78M | 441.18M | 346.58M | 267.55M | 82.43M |
| Total Equity | 432.74M | 497.37M | 375.34M | 294.96M | 82.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -144.4M | 169.88M | -233.25M | -223.63M | -224.84M |
| Investing | -59.8M | -271.63M | 248.2M | 59.29M | 153.53M |
| Financing | 142.03M | 153.1M | 32.86M | 84.66M | 14.59M |
| Market Cap | 2.75B |
| Price to Earnings Ratio | -0.83 |
| Price to Sales Ratio | 1.22 |
| Price to Cash Ratio | 4.75 |
| Price to Book Ratio | 2.59 |
| Dividend Yield | - |
| Shares Outstanding | 177.35M |
| Average Volume (1 week) | 341.56k |
| Average Volume (1 Month) | 216.24k |
| 52 Week Change | 0.00% |
| 52 Week High | 15.50 |
| 52 Week Low | 15.50 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Sangamo Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.sangamo.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
